Carotid stenting versus carotid endarterectomy: Evidence basis and cost implications

MP Janssen, GJ de Borst, WPTM Mali, LJ Kappelle, FL Moll, RGA Ackerstaff, PM Rothwell, MM Brown, Marc Sambeek, E Buskens

Research output: Contribution to journalArticleAcademicpeer-review

28 Citations (Scopus)


Objective: Carotid Angioplasty combined with Stenting (CAS) is increasingly performed because of its presumed benefits. A study was performed to identify key factors that determine the cost-effectiveness as compared to conventional carotid endarterectomy (CEA). Methods: The incremental cost-effectiveness of CAS over CEA for different scenarios was estimated using a modeling approach. Treatment costs were based on actual costs of successful procedures whereas costs of complications were taken from the literature. Patient survival was modeled using the endarterectomy patients from the ECST trial. Results: Procedural costs of CAS are higher than those of CEA, mainly as a result of the high material costs. Cost-effectiveness of CAS primarily depends on major stroke rates. One percent increase in the peri-operative major stroke rate causes a cost increase of El 051 and a loss of 0.06 quality adjusted life years. Conclusions: At present CAS is at best non-inferior to CEA in terms of clinical outcome. Cost savings due to shorter admission are offset by the high costs associated with catheter-based interventions. At present CAS should be restricted to controlled settings until clinical trials have shown a substantial clinical benefit. (C) 2008 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
Original languageUndefined/Unknown
Pages (from-to)258-264
Number of pages7
JournalEuropean Journal of Vascular and Endovascular Surgery
Issue number3
Publication statusPublished - 2008

Cite this